U.S. Markets closed

Insys Therapeutics Inc. Registe (NPR1.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
12.40-0.03 (-0.27%)
At close: 7:21PM CEST
People also watch
Interactive chart
Previous Close12.43
Bid0.00 x 100000
Ask0.00 x 100000
Day's Range12.40 - 12.76
52 Week Range0.04 - 12.76
Avg. Volume0
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Investopedia1 hour ago

    Pot Stock Winners of the Week

    The FDA's approval of a drug to combat chemotherapy-induced nausea sent one medical marijuana stock flying.

  • Reuters22 hours ago

    Alabama 'pill mill' doctor tied to Insys gets 21 years in prison

    An Alabama doctor was sentenced on Friday to 21 years in prison for running two clinics with a colleague that prosecutors called a massive "pill mill," in a case tied to the U.S. probe of Insys Therapeutics Inc. Xiulu Ruan, who with John Couch ran the Physicians Pain Specialists of Alabama clinics, was sentenced by U.S. District Judge Callie Granade in Mobile, Alabama, after a jury in March found them guilty of racketeering conspiracy and other felonies. Gordon Armstrong, a lawyer for Ruan, said he planned to appeal.

  • GlobeNewswire3 days ago

    Insys Therapeutics, Inc. Announces FDA Final Product Label for Syndros

    PHOENIX, May 24, 2017-- Insys Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has approved the final product label for Syndros™ oral solution, CII, a liquid formulation of ...